A sea change in EU data disclosure plans?
This article was originally published in SRA
Is the European Medicines Agency really putting the brakes on its plans for wider public access to clinical trial data? It looks that way. After flying the flag of greater disclosure, and in the process bringing some major companies on board, it seems the wind has gone out of the agency's sails, deflated perhaps by strong headwinds from across the Atlantic1,2.